Former Senior Vice President and Chief Commercial Officer · QUEST DIAGNOSTICS INC (DGX)

Manuel Mendez

A named executive officer of QUEST DIAGNOSTICS in every fiscal year CompBrief holds from FY2019 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$3,532,418

Salary $572,308Stock awards $1,364,907

FY2019: $4,583,114

4th of 5 named executive officers at Quest Diagnostics by FY2020 total.

5 named officers on file for QUEST DIAGNOSTICS, FY2020

Manuel Mendez’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 6 equity grants, each cited to its filing
  • DGX’s disclosed peer group of 14 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how QUEST DIAGNOSTICS’s whole pay program stands against its peers

  • QUEST DIAGNOSTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on DGX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 9, 2021 (DEF 14A).

Free

Get Manuel Mendez’s full pay file as a PDF — free

More than this page: up to 10 years of Manuel’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Manuel Mendez compensation by year

QUEST DIAGNOSTICS Summary Compensation Table · all 2 fiscal years held
In US dollars, as QUEST DIAGNOSTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020
Salary$147,962$572,308
Bonus$800,000—
Stock awards$2,888,517$1,364,907
Option awards$266,635$600,011
Non-equity incentive$480,000$0
Pension and deferred compensation$0$0
All other$0$995,192
Total$4,583,114$3,532,418

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: QUEST DIAGNOSTICS INC DEF 14A filed April 9, 2021, accession 0000930413-21-000760, and prior-year filings. Open the filing on EDGAR.

How this page was built: the QUEST DIAGNOSTICS INC filed document, accession 0000930413-21-000760. Every figure is read from that document and cited to the page and table it appears in. Filed April 9, 2021.

$4.6M
$3.5M
FY19
FY20
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU11,690$1,393,097—
PSU6,749$804,278—
RSU5,350$637,560—
PSU2,494$297,210—
RSU936$111,543—
Option34,887—$112.17
Option10,647—$106.94

Per the Outstanding Equity Awards at Fiscal Year-End table in QUEST DIAGNOSTICS INC's FY2020 proxy; value at the fiscal year-end close, as the company printed it.

QUEST DIAGNOSTICS’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Stephen H. RusckowskiChairman, CEO and President$14,081,608
Mark J. GuinanExecutive Vice President and Chief Financial Officer$3,803,424
James E. DavisExecutive Vice President, General Diagnostics$3,694,706
Manuel Mendez · this pageFormer Senior Vice President and Chief Commercial Officer$3,532,418
Carrie MannerSenior Vice President, Advanced Diagnostics$3,278,981

The full QUEST DIAGNOSTICS compensation record

free company brief

This page is one person within QUEST DIAGNOSTICS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the QUEST DIAGNOSTICS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are QUEST DIAGNOSTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Manuel Mendez's compensation dossier · One-time report. No refunds.